Published in Trop Med Int Health on January 01, 2014
Primary and Secondary HIV Prevention Among Persons with Severe Mental Illness: Recent Findings. Curr HIV/AIDS Rep (2015) 0.75
Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08
RE: Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults by JM Nachega et al. (2013), TMIH 18, pp 53–57. Trop Med Int Health (2014) 1.08
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA (2006) 11.71
Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med (2006) 8.57
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med (2007) 6.26
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr (2006) 4.81
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med (2011) 4.68
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr (2009) 3.41
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med (2008) 2.82
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med (2007) 2.48
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev (2014) 2.43
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. Lancet (2009) 2.35
Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health (2012) 2.08
Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav (2012) 2.01
Low lopinavir plasma or hair concentrations explain second-line protease inhibitor failures in a resource-limited setting. J Acquir Immune Defic Syndr (2011) 1.98
Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosis. BMC Infect Dis (2009) 1.92
Study protocol: The Improving Care of Acute Lung Injury Patients (ICAP) study. Crit Care (2006) 1.89
Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS (2008) 1.85
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc (2007) 1.69
Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One (2011) 1.56
Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings. J Infect Dis (2013) 1.55
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study. Crit Care Med (2014) 1.49
Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc (2011) 1.46
Guiding the development of family medicine training in Africa through collaboration with the Medical Education Partnership Initiative. Acad Med (2014) 1.46
The impact of conflict on HIV/AIDS in sub-Saharan Africa. Int J STD AIDS (2006) 1.45
Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23
Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model. J Acquir Immune Defic Syndr (2013) 1.18
Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy. AIDS (2011) 1.16
Timing of tuberculosis transmission and the impact of household contact tracing. An agent-based simulation model. Am J Respir Crit Care Med (2014) 1.09
Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia. Am J Epidemiol (2013) 1.09
Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings. J Int Assoc Physicians AIDS Care (Chic) (2010) 1.05
Test and treat: a new standard for smear-positive tuberculosis. J Acquir Immune Defic Syndr (2012) 1.00
Studying outcomes of intensive care unit survivors: measuring exposures and outcomes. Intensive Care Med (2005) 1.00
Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia. PLoS One (2013) 0.97
Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity. J Acquir Immune Defic Syndr (2013) 0.96
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis. Ther Clin Risk Manag (2012) 0.95
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana. PLoS One (2011) 0.94
Serological tests for the diagnosis of active tuberculosis: relevance for India. Indian J Med Res (2012) 0.93
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis. Ann Clin Microbiol Antimicrob (2009) 0.93
Patient-nominated, community-based HIV treatment supporters: patient perspectives, feasibility, challenges, and factors for success in HIV-infected South African adults. AIDS Patient Care STDS (2013) 0.93
Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs. J Infect Dis (2013) 0.91
Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis. PLoS One (2013) 0.91
Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis. Clin Infect Dis (2013) 0.89
Lifetime depressive disorders and adherence to anti-retroviral therapy in HIV-infected Ugandan adults: a case-control study. J Affect Disord (2012) 0.88
A wake-up call for global access to salvage HIV drug regimens. Lancet (2007) 0.88
Cross-cultural adaptation and validation of the self-reporting questionnaire among HIV+ individuals in a rural ART program in southern Uganda. HIV AIDS (Auckl) (2012) 0.88
The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa. Curr HIV Res (2014) 0.87
Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study. Patient Prefer Adherence (2013) 0.87
Fever is associated with delayed ventilator liberation in acute lung injury. Ann Am Thorac Soc (2013) 0.85
Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis. AIDS Res Ther (2013) 0.85
Screening for Tuberculosis Among Adults Newly Diagnosed With HIV in Sub-Saharan Africa: A Cost-Effectiveness Analysis. J Acquir Immune Defic Syndr (2015) 0.85
The global status of HIV drug resistance: clinical and public-health approaches for detection, treatment and prevention. Infect Disord Drug Targets (2011) 0.84
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.83
Tests for latent tuberculosis infection and isoniazid preventive therapy. Lancet Infect Dis (2012) 0.82
Post-2015 tuberculosis strategies in a pre-2015 world. Int J Tuberc Lung Dis (2013) 0.82
Patient Follow-up in an Urban Resident Continuity Clinic: An Initiative to Improve Scheduling Practices. J Grad Med Educ (2011) 0.82
Earlier initialization of highly active antiretroviral therapy is associated with long-term survival and is cost-effective: findings from a deterministic model of a 10-year Ugandan cohort. J Acquir Immune Defic Syndr (2012) 0.81
Economic analyses of diagnostics for tuberculosis: what's the point? Expert Rev Pharmacoecon Outcomes Res (2012) 0.81
Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics. Br J Clin Pharmacol (2012) 0.80
Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis. BMC Infect Dis (2014) 0.80
Sub-optimal CD4 T-lymphocyte responses among HIV infected patients who develop TB during the first year of ART. J AIDS Clin Res (2012) 0.79
HIV infection as a weapon of war. Lancet Infect Dis (2006) 0.79
Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV. AIDS (2015) 0.79
Targeting HIV: past, present and future. Infect Disord Drug Targets (2011) 0.78
HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey. J Int Assoc Provid AIDS Care (2014) 0.78
Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. J Clin Microbiol (2013) 0.78
Cost-consequence analysis of multimodal interventions with environmental components for pediatric asthma in the state of Maryland. J Asthma (2013) 0.78
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (2016) 0.78
Progression and persistence of low-grade cervical squamous intraepithelial lesions in women living with human immunodeficiency virus. J Low Genit Tract Dis (2012) 0.77
Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa. Clin Infect Dis (2014) 0.77
The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. J Acquir Immune Defic Syndr (2017) 0.76
CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int J Epidemiol (2015) 0.76
Vitamin A and D deficiencies associated with incident tuberculosis in HIV-infected patients initiating antiretroviral therapy in multinational case-cohort study. J Acquir Immune Defic Syndr (2017) 0.75
Authors' response to: Epidemiology and public health research productivity in Africa. Int J Epidemiol (2013) 0.75
Thinking outside the box: intensive care unit diaries to improve psychological outcomes in family members*. Crit Care Med (2012) 0.75
Cost-effectiveness of Diagnostic Algorithms for Tuberculosis in Children Less Than 5 Years of Age. Pediatr Infect Dis J (2017) 0.75
The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. J Acquir Immune Defic Syndr (2017) 0.75
Strategies to Accelerate HIV Care and Antiretroviral Therapy Initiation Following HIV Diagnosis: a Randomized Trial. J Acquir Immune Defic Syndr (2017) 0.75
Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis. Am J Epidemiol (2016) 0.75
Targeting tuberculosis and HIV/AIDS: a global progress report of a deadly partnership. Infect Disord Drug Targets (2011) 0.75
Methodology matters: what type of research is suitable for evaluating community treatment supporters for HIV and tuberculosis treatment? Trop Med Int Health (2011) 0.75